- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Beijing Chest Hospital
I alt 3300 resultater
-
Beijing Chest HospitalIkke rekrutterer endnuFejlernæring | Lungekræft | Aminosyre mangel
-
Beijing Chest HospitalRekruttering
-
Beijing Chest HospitalUkendtIkke-småcellet lungekræftKina
-
Beijing Chest HospitalIkke rekrutterer endnu
-
Beijing Chest HospitalRekrutteringTuberkulose, lungeKina
-
Beijing Chest HospitalUkendt
-
Beijing Chest HospitalUkendt
-
Beijing Chest HospitalIkke rekrutterer endnuSmåcellet lungekræft i omfattende stadie
-
Beijing Chest HospitalRekruttering
-
Beijing Chest HospitalRekruttering
-
Beijing Chest HospitalAfsluttetMulti-drug Resistent TuberkuloseKina
-
Beijing Chest HospitalAktiv, ikke rekrutterendeMultiresistent tuberkuloseKina
-
Beijing Chest HospitalUkendt
-
Beijing Tongren HospitalBeijing Chest HospitalRekrutteringPostoperative lungekomplikationerKina
-
Beijing Chest HospitalShandong Chest Hospital; Zhengzhou Sixth People's HospitalAktiv, ikke rekrutterendeSensitiv lungetuberkuloseKina
-
Beijing Chest HospitalBeijing Municipal Science & Technology CommissionUkendtTuberkulose, SpinalKina
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalAfsluttetLungeneoplasmer | Adenocarcinom i lunge | Lungekræft, ikke-småcellet | Planocellulær lungekræftKina
-
Geneplus-Beijing Co. Ltd.Shanghai Chest HospitalRekrutteringLungeneoplasmer | Adenocarcinom i lunge | Lungekræft, ikke-småcellet | Planocellulær lungekræftKina
-
Beijing Chest HospitalJiangsu HengRui Medicine Co., Ltd.Ukendt
-
Tianjin Chest HospitalLinkDoc Technology (Beijing) Co. Ltd.AfsluttetIkke-småcellet lungekræftKina
-
Beijing Chest HospitalJiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnuHER2 mutant ikke-småcellet lungekræft
-
Chengdu CoenBiotech Co., LtdBeijing Friendship Hospital; Beijing Chest Hospital, Capital Medical UniversityAfsluttet
-
Peking Union Medical College HospitalBeijing Chao Yang Hospital; Beijing Hospital; Beijing Chest Hospital; China-Japan...UkendtSmåcellet lungekræft i omfattende stadieKina
-
Beijing Chest HospitalNational Medical Center for Infectious DiseasesRekrutteringLungetuberkulose | Rifampicin-resistent tuberkuloseKina
-
Shanghai Chest HospitalIkke rekrutterer endnuEsophageal pladecellekarcinomKina
-
Shanghai Chest HospitalIkke rekrutterer endnuKirurgisk procedure, uspecificeretKina
-
Shanghai Chest HospitalRekrutteringSmåcellet lungekarcinom | Småcellet lungekræft | Småcellet lungekræft begrænset stadie | Småcellet lungekræft omfattende stadie | Småcellet lungekræft, kombineret typeKina
-
Shanghai Chest HospitalRekrutteringNSCLC | NSCLC trin IV | NSCLC, tilbagevendendeKina
-
Shanghai Chest HospitalRekrutteringThymisk karcinom | Thymisk epiteltumor | ThymuskræftKina
-
Tianjin Chest HospitalRekruttering
-
Shanghai Chest HospitalIkke rekrutterer endnu
-
Shanghai Chest HospitalRekruttering
-
Tianjin Chest HospitalRekrutteringKoronararteriesygdom | Større uønskede kardiovaskulære hændelser | Koronar computertomografi angiografi | Revaskularisering | Stabil brystsmerter | Optimal medicinsk terapi | Invasiv koronar angiografiKina
-
Shanghai Chest HospitalRekruttering
-
Tianjin Chest HospitalRekrutteringAkut koronarsyndrom uden ST-segmentKina
-
Shanghai Chest HospitalAktiv, ikke rekrutterendeSmåcellet lungekræft i omfattende stadieKina
-
Shanghai Chest HospitalAfsluttetAtrieflimren, vedvarendeKina
-
Shanghai Chest HospitalUkendtStrålebehandling | Ikke-småcellet lungekræft stadie IIIAKina
-
Shanghai Chest HospitalUkendtDiagnostiserer sygdomKina
-
Shanghai Chest HospitalUkendt
-
Shanghai Chest HospitalUkendt
-
Shanghai Chest HospitalUkendt
-
Shanghai Chest HospitalUkendtEndobronchial ultralyd
-
Shanghai Chest HospitalAfsluttetHøjre hjertesvigt | Trikuspidal regurgitationKina
-
Shanghai Chest HospitalUkendtPulmonal storcellet neuroendokrin karcinom
-
Shanghai Chest HospitalUkendt
-
Shanghai Chest HospitalUkendt
-
Shanghai Chest HospitalUkendtAkut nyresvigt | Akut hjertesvigtKina
-
Shanghai Chest HospitalRekrutteringLungeneoplasmer | Psykisk nød | IMMUNOTERAPI | Livsstil, sund | Målrettet molekylær terapi | PrognosefaktorerKina